NCT04906837View on ClinicalTrials.gov

Pre TAVI Membranous Septum Measurement Predicts High Grade Iatrioventricular Conduction Disorders in Patients With Specific Pacemaker Implanted After TAVI. The STIM TAVI-MS Study

CompletedOBSERVATIONAL
Enrollment

197

Participants

Timeline

Start Date

June 20, 2020

Primary Completion Date

February 26, 2021

Study Completion Date

February 26, 2021

Conditions
Conduction DisturbanceTrans Aortic Valve Implantation (TAVI)
Interventions
DIAGNOSTIC_TEST

Trans aortic valve implantation

Measurement of the membranous septum on the pre TAVI scanner and the valve implantation height

Trial Locations (1)

74370

CH Annecy Genevois, Annecy

All Listed Sponsors
lead

Association de Recherche en Cardiologie des Alpes

OTHER

NCT04906837 - Pre TAVI Membranous Septum Measurement Predicts High Grade Iatrioventricular Conduction Disorders in Patients With Specific Pacemaker Implanted After TAVI. The STIM TAVI-MS Study | Biotech Hunter | Biotech Hunter